You’re on our free tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
Nigeria
Politics
Crime
Premier League
Economy
Africa
World
Entertainment
Sport
La Liga
Serie A
Bundesliga
Lifestyle
Bitcoin
Cryptocurrencies
Sensational News

Blood Cancer
Cancer
CAR-T
Ovarian Cancer
Cancer Treatment
Breast Cancer
Lung Cancer
Cancer Research
HPV
Topics

Advertisement

Blood Cancer

Share

Top Latest Popular

Blocking cathepsin B protein enhances CAR T-cell therapy effectiveness Drug Target Review 2d

Drug Target Review 2d

EHA26: BMS touts positive multiple myeloma data for two pipeline candidates Pharmaceutical Technology 11:18 Wed, 17 Jun

Pharmaceutical Technology 11:18 Wed, 17 Jun

EHA26: J&J’s multiple myeloma therapies impress with new data Pharmaceutical Technology 18:01 Tue, 16 Jun

Pharmaceutical Technology 18:01 Tue, 16 Jun

Advertisement

[Interview] 'New multiple myeloma drug brought about a miracle when I was about to give up' Korea Biomedical Review 07:36 Tue, 16 Jun

Korea Biomedical Review 07:36 Tue, 16 Jun

Advertisement

Data could move J&J's Talvey earlier in myeloma therapy pharmaphorum 11:21 Mon, 15 Jun

pharmaphorum 11:21 Mon, 15 Jun

Cancer patient in remission after 'amazing' outcome of targeted trial ABC Online 00:11 Tue, 16 Jun

ABC Online 00:11 Tue, 16 Jun

Advertisement

Advertisement

Latest

In the last 6 hours

PFS Improved With Talquetamab in Relapsed or Refractory Multiple Myeloma Hematology Advisor 14:23

Talquetamab-Based Regimens Improve Survival in Relapsed/Refractory Multiple Myeloma Oncology Nurse Advisor 14:05

Earlier Today

Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma Nature.com 02:02

Gilead to refile Yescarta reimbursement bid after Korea review stalls Korea Biomedical Review 01:42

Yesterday

Long-Term CAR-T Results in Lymphoma Confirm Early Promise Medpage Today 22:50 Wed, 24 Jun

Mum thought she just had a 'bad cold' - but it was something way more serious The Mirror 12:05 Wed, 24 Jun

Tuesday

HD-MTX Prophylaxis Failed to Reduce CNS Relapse in Ultra High-Risk Large B-Cell Lymphoma Hematology Advisor 16:48 Tue, 23 Jun

Blocking cathepsin B protein enhances CAR T-cell therapy effectiveness Drug Target Review 12:55 Tue, 23 Jun

Monday

Wearable Devices May Help Detect Cytokine Release Syndrome Earlier in Patients Receiving CAR-T Therapy Newswise (Press Release) 19:29 Mon, 22 Jun

Mum's metallic taste in her mouth revealed as incurable cancer sign Manchester Evening News 19:10 Mon, 22 Jun

Advertisement

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

- Cancer Cancer
  Back to Health & Fitness Cancer
  - Blood Cancer
  - Breast Cancer
  - Cancer Research
  - Cancer Treatment
  - CAR-T CAR-T
  - Cervical Cancer
  - Cervical Screening
  - Colorectal Cancer
  - HPV HPV
  - Leukaemia Leukaemia
  - Lung Cancer
  - Ovarian Cancer
  - Prostate Cancer